title: Importance of the terminal portion of tumor time-activity curve in determining tumor dosimetry in radioimmunotherapy.
authors.forename: R L
authors.initials: RL
authors.lastname: Wahl
authors.forename: K
authors.initials: K
authors.lastname: Zasadny
authors.forename: M S
authors.initials: MS
authors.lastname: Kaminski
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D016393:Lymphoma, B-Cell / Q000628:therapy*; D011879:Radiotherapy Dosage
chemical_list: D000911:Antibodies, Monoclonal; D007457:Iodine Radioisotopes